Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical Neoplasias
- Alternative title
-
Die Bedeutung der HPV-Genotypisierung für Screening, Therapie und Management der zervikalen Neoplasien
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical Neoplasias ; volume:72 ; number:06 ; year:2012 ; pages:507-512
Geburtshilfe und Frauenheilkunde ; 72, Heft 06 (2012), 507-512
- Contributor
-
Jentschke, M.
Soergel, P.
Hillemanns, P.
- DOI
-
10.1055/s-0032-1314959
- URN
-
urn:nbn:de:101:1-2019050210182108742174
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jentschke, M.
- Soergel, P.
- Hillemanns, P.
Other Objects (12)
HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic cervical epithelial changes
Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China
Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias
Diagnostic accuracy of extended HPV DNA genotyping and its application for risk-based cervical cancer screening strategy
Cervical Cancer Screening and HPV Vaccination in Nepal
Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation
Erratum: Cervical Cancer Screening and HPV Vaccination in Nepal
Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic cervical epithelial changes
Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China
Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias
Diagnostic accuracy of extended HPV DNA genotyping and its application for risk-based cervical cancer screening strategy
Cervical Cancer Screening and HPV Vaccination in Nepal
Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation
Erratum: Cervical Cancer Screening and HPV Vaccination in Nepal
Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic cervical epithelial changes
Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China
Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias
Diagnostic accuracy of extended HPV DNA genotyping and its application for risk-based cervical cancer screening strategy
Cervical Cancer Screening and HPV Vaccination in Nepal
Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation
Erratum: Cervical Cancer Screening and HPV Vaccination in Nepal
Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples